• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features.蔗糖非发酵相关激酶在卵巢癌中的表达及其与临床特征的相关性
Cancer Invest. 2017 Aug 9;35(7):456-462. doi: 10.1080/07357907.2017.1337781. Epub 2017 Jul 19.
2
Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.上皮性卵巢癌中polo样蛋白激酶1、P53和P21WAF1的调控异常提示预后不良。
Oncol Rep. 2015 Mar;33(3):1235-42. doi: 10.3892/or.2015.3723. Epub 2015 Jan 15.
3
Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer.ATP 柠檬酸裂解酶表达增加对人上皮性卵巢癌的预后和治疗意义。
Oncol Rep. 2012 Apr;27(4):1156-62. doi: 10.3892/or.2012.1638. Epub 2012 Jan 16.
4
Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.阿贝尔森相互作用蛋白1的上调预示上皮性卵巢癌的肿瘤进展和不良预后。
Hum Pathol. 2015 Sep;46(9):1331-40. doi: 10.1016/j.humpath.2015.05.015. Epub 2015 May 30.
5
Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.富含半胱氨酸的血管生成诱导因子61在卵巢上皮癌患者中的表达
J Int Med Res. 2014 Apr;42(2):300-6. doi: 10.1177/0300060513505268. Epub 2014 Mar 4.
6
Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.类stomatin蛋白2在上皮性卵巢癌中过表达,并预示患者预后不良。
BMC Cancer. 2015 Oct 20;15:746. doi: 10.1186/s12885-015-1723-x.
7
Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.Aurora B 的过表达与上皮性卵巢癌患者的不良预后相关。
Virchows Arch. 2009 Nov;455(5):431-40. doi: 10.1007/s00428-009-0838-3. Epub 2009 Oct 17.
8
[Expression and significance of matriptase in ovarian cancer cells with diverse metastatic potential].[不同转移潜能卵巢癌细胞中胃蛋白酶原的表达及意义]
Zhonghua Fu Chan Ke Za Zhi. 2013 May;48(5):370-4.
9
Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.由极光激酶A(Aurora-A)诱导但受乳腺癌2号基因(BRCA2)抑制的原纤蛋白-1可促进卵巢癌转移。
Oncotarget. 2015 Mar 30;6(9):6670-83. doi: 10.18632/oncotarget.3118.
10
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.在非浆液性上皮性卵巢癌患者中,FOXM1表达与化疗耐药及不良预后显著相关。
J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y.

引用本文的文献

1
SNRK: a metabolic regulator with multifaceted role in development and disease.丝氨酸/苏氨酸蛋白激酶相关激酶(SNRK):一种在发育和疾病中具有多方面作用的代谢调节因子。
Vessel Plus. 2020;4. Epub 2020 Aug 21.

本文引用的文献

1
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism.蔗糖非发酵相关激酶酶对于心脏代谢至关重要。
Biol Open. 2014 Dec 12;4(1):48-61. doi: 10.1242/bio.20149811.
3
Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammation.鉴定蔗糖非发酵相关激酶(SNRK)为脂肪细胞炎症的抑制物。
Diabetes. 2013 Jul;62(7):2396-409. doi: 10.2337/db12-1081. Epub 2013 Mar 21.
4
Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin.Snf1 相关激酶通过钙调蛋白结合蛋白依赖性降低 β-连环蛋白抑制结肠癌细胞增殖。
FASEB J. 2012 Nov;26(11):4685-95. doi: 10.1096/fj.12-212282. Epub 2012 Aug 8.
5
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.脂肪细胞促进卵巢癌转移,并为肿瘤的快速生长提供能量。
Nat Med. 2011 Oct 30;17(11):1498-503. doi: 10.1038/nm.2492.
6
The AMPK/SNF1/SnRK1 fuel gauge and energy regulator: structure, function and regulation.AMPK/SNF1/SnRK1 燃料计和能量调节剂:结构、功能和调节。
FEBS J. 2011 Nov;278(21):3978-90. doi: 10.1111/j.1742-4658.2011.08315.x. Epub 2011 Sep 26.
7
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.mTOR 抑制剂替西罗莫司治疗持续性和复发性上皮性卵巢癌和原发性腹膜癌的 II 期临床试验:一项妇科肿瘤学组研究。
Gynecol Oncol. 2011 Oct;123(1):19-26. doi: 10.1016/j.ygyno.2011.06.022. Epub 2011 Jul 12.
8
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.蛋白激酶激活剂的研发:以AMPK作为代谢紊乱和癌症的靶点
Biochim Biophys Acta. 2010 Mar;1804(3):581-91. doi: 10.1016/j.bbapap.2009.09.012. Epub 2009 Sep 22.
9
Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates.Snrk-1参与血管母细胞发育的多个步骤,并在脊椎动物的动静脉特化过程中通过Notch信号通路发挥作用。
Blood. 2009 Jan 29;113(5):1192-9. doi: 10.1182/blood-2008-06-162156. Epub 2008 Aug 22.
10
AMPK phosphorylation of raptor mediates a metabolic checkpoint.Raptor的AMPK磷酸化介导代谢检查点。
Mol Cell. 2008 Apr 25;30(2):214-26. doi: 10.1016/j.molcel.2008.03.003.

蔗糖非发酵相关激酶在卵巢癌中的表达及其与临床特征的相关性

Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features.

作者信息

Hopp Elizabeth E, Cossette Stephanie M, Kumar Suresh N, Eastwood Daniel, Ramchandran Ramani, Bishop Erin

机构信息

a Department of Obstetrics and Gynecology , Medical College of Wisconsin , Milwaukee , Wisconsin , USA.

b Department of Pediatrics, Children's Research Institute, Division of Neonatology , Medical College of Wisconsin , Milwaukee , Wisconsin , USA.

出版信息

Cancer Invest. 2017 Aug 9;35(7):456-462. doi: 10.1080/07357907.2017.1337781. Epub 2017 Jul 19.

DOI:10.1080/07357907.2017.1337781
PMID:28722495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6167932/
Abstract

Sucrose non-fermenting related kinase (SNRK) is a serine/threonine kinase known to regulate cellular metabolism and adipocyte inflammation. Since alterations in adipocyte metabolism play a role in ovarian cancer metastasis, we investigated the expression of SNRK in benign and malignant human ovarian tissue using immunohistochemistry and qPCR. The number of SNRK positive (+) nuclei is increased in malignant tissue compared to benign tissue (21.03% versus 14.90%, p < .0431). The most strongly stained malignant SNRK+ nuclei were stage 1 compared to stage 2-4 disease. Differential expression of SNRK in early versus late stage disease suggests specific roles for SNRK in ovarian cancer metastasis.

摘要

蔗糖非发酵相关激酶(SNRK)是一种丝氨酸/苏氨酸激酶,已知其可调节细胞代谢和脂肪细胞炎症。由于脂肪细胞代谢的改变在卵巢癌转移中起作用,我们使用免疫组织化学和定量聚合酶链反应(qPCR)研究了SNRK在人卵巢良性和恶性组织中的表达。与良性组织相比,恶性组织中SNRK阳性(+)细胞核的数量增加(21.03%对14.90%,p < 0.0431)。与2-4期疾病相比,1期恶性SNRK+细胞核的染色最强。SNRK在疾病早期和晚期的差异表达表明其在卵巢癌转移中具有特定作用。